Deep vein thrombosis

4 trials 1 recruiting MedDRA PT
4 Registered trials
1 Recruiting
3 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
B Haematology (ATC B) 1
Mechanism of action (INN-stem analysis)
Factor Xa inhibitor (DOAC) 1 substance
Phase III: 2 Other: 2

Filter these 4 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 4 trials

Phase III

2 trials
  • Centre Hospitalier Regional Et Universitaire De Brest Academic
    IMP not specified
    2023-504486-23-00 2 countries 2024 n=750
    Recruiting
  • Klinikum der Universitaet Muenchen AöR Academic
    APIXABAN
    2024-515630-33-00 1 country n=27,698
    Ended

Other

2 trials
  • Celon Pharma S.A. Commercial
    IMP not specified
    2024-511526-31-00 1 country 2024 n=38
    Ended
  • Celon Pharma S.A. Commercial
    IMP not specified
    2024-519660-40-00 1 country 2025 n=38
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Celon Pharma S.A. Commercial 2 Other 0
Centre Hospitalier Regional Et Universitaire De Brest Academic 1 Phase III 1
Klinikum der Universitaet Muenchen AöR Academic 1 Phase III 0
New trials by year
2024
2
2025
1
← All indication landscapes